TFF3 and hepatocellular carcinoma: Cabyr also reduces cell proliferation when knocked down in liver cancer cells [29]; Cspg5 is one of 6 genes that, together, predict HCC patient survival [30]; Mthfd1l predicts HCC patient survival [31]; Tff3 also predicts HCC patient survival, and changing its expression in HCC cells affects the cells’ oncogenicity [32].